XML 26 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents (Note 2 (e)) $ 67,267 $ 38,726
Accounts receivable, net of provision for credit losses (Notes 2 (g), (h) and 3) 8,280 9,110
Deferred voyage expenses (Note 2 (n)) 0 20
Inventories (Note 2 (i)) 2,203 3,037
Prepaid expenses and other assets 2,164 2,524
Current assets from discontinued operations (Note 2 (y)) 0 46
Total current assets 79,914 53,463
FIXED ASSETS:    
Advances for vessels under construction and other vessels' costs (Note 5) 11,303 0
Vessels, net (Notes 2 (j), (k), (l) and 6) 202,108 236,607
Property and equipment, net 44 72
Total fixed assets 213,455 236,679
NON-CURRENT ASSETS:    
Restricted cash, non-current (Notes 2 (f) and 7) 1,000 1,000
Right of use asset under operating leases (Note 8) 99 163
Deferred charges, net (Note 2 (p)) 1,798 1,098
Other non-current assets (Notes 2 (j) and 6) 0 522
Prepaid charter revenue 0 54
Total non-current assets 2,897 2,837
Total assets 296,266 292,979
CURRENT LIABILITIES:    
Current portion of long-term bank debt, net of unamortized deferred fin. costs (Note 7) 7,427 16,746
Accounts payable, trade and other 4,630 4,580
Due to related parties (Note 4) $ 245 $ 335
Other Liability, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Accrued liabilities $ 2,976 $ 2,889
Deferred revenue (Note 3) 0 1,378
Lease liabilities, current (Note 8) 66 73
Current liabilities from discontinued operations (Note 2 (y)) 0 98
Total current liabilities 15,344 26,099
LONG-TERM LIABILITIES:    
Long-term bank debt, net of unamortized deferred financing costs (Note 7) 47,459 110,929
Other liabilities, non-current 214 156
Long-term lease liabilities (Note 8) 33 90
Commitments and contingencies (Note 8) 0 0
Fair value of warrants' liability (Note 9) 32 0
Total long-term liabilities 47,738 111,175
STOCKHOLDERS' EQUITY:    
Preferred stock, $0.01 par value; 25,000,000 shares authorized, 50,726 and 136,261 Series B, and 1,428,372 and 1,314,792 Series C issued and outstanding as at December 31, 2023 and 2022, respectively (Note 9) 15 15
Common stock, $0.01 par value; 500,000,000 shares authorized; 12,279,676 and 4,187,588 issued and outstanding as at December 31, 2023 and 2022, respectively (Note 9) 123 42
Additional paid-in capital (Note 9) 534,112 513,623
Other comprehensive income 49 66
Accumulated deficit (301,115) (358,041)
Total stockholders' equity 233,184 155,705
Total liabilities and stockholders' equity $ 296,266 $ 292,979